Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dialysis Corp Of America
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dialysis Corp Of America since year 2005.
Table 2 shows the detailed insider transactions of Dialysis Corp Of America since 2005.
The reporting company's ticker symbol is DCAI. The reporting company's CIK number is 201653.
The total value of stock buying since 2005 is $51,645.
The total value of stock sales since 2005 is $4,584,334.
The total value of stock option exercises since 2005 is $766,489.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2009-06-08||Bienenstock Alexander (Director)||Option Ex||1,417||4.02||5,696|
|2009-06-08||Trause Robert W (Director)||Option Ex||1,417||4.02||5,696|
|2009-06-08||Fischbein Peter D (Director)||Option Ex||5,000||4.02||20,099|
|2009-06-01||Bienenstock Alexander (Director)||Sale||2,000||5.20||10,400|
|2009-05-29||Zimmerman Joanne (VP, Clinical Services)||Buy||1,000||4.60||4,600|
|2009-05-15||Carey Thomas Patrick (VP, Operations)||Buy||3,500||4.42||15,470|
|2009-05-15||Everett Stephen W (President & CEO)||Buy||1,500||4.55||6,825|
|2009-05-14||Zimmerman Joanne (VP, Clinical Services)||Buy||700||4.38||3,066|
|2008-06-24||Carey Thomas Patrick (Vice President, Operations)||Buy||1,500||7.22||10,830|
|2008-06-10||Jeanneret Andrew J (VP Finance, CFO)||Buy||700||7.30||5,110|
|2008-06-09||Jeanneret Andrew J (VP Finance, CFO)||Buy||800||7.18||5,744|
|2007-10-08||Bienenstock Alexander (Director)||Sale||6,295||9.23||58,102|
|2007-10-02||Bienenstock Alexander (Director)||Sale||1,705||9.58||16,333|
|2007-10-01||Bienenstock Alexander (Director)||Sale||2,000||9.70||19,400|
|2007-01-12||Langbein Thomas K (Director)||Sale||1,900||13.87||26,353|
|2007-01-09||Langbein Thomas K (Director)||Sale||100||13.85||1,385|
|2006-08-16||Bienenstock Alexander (Director)||Sale||10,000||13.10||131,000|
|2006-03-29||Rowe Michael (Vice President, Operations)||Option Ex||175,000||2.19||383,250|
|2006-03-22||Everett Stephen W (President and CEO)||Sale||18,376||13.51||248,259|
|2006-03-13||Fischbein Peter D (Director)||Sale||8,806||12.75||112,276|
|2006-03-09||Fischbein Peter D (Director)||Sale||200||12.75||2,550|
|2006-03-08||Fischbein Peter D (Director)||Sale||10,994||12.76||140,283|
|2006-03-07||Everett Stephen W (President and CEO)||Option Ex||37,500||4.02||150,749|
|2006-03-07||Langbein Thomas K (Director)||Option Ex||50,000||4.02||200,999|
|2005-11-23||Everett Stephen W (President and CEO)||Sale||81,624||13.69||1,117,432|
|2005-11-23||Langbein Thomas K (Director)||Sale||70,000||13.82||967,050|
|2005-11-18||Langbein Thomas K (Director)||Sale||40,000||12.68||507,200|
|2005-11-15||Langbein Thomas K (Director)||Sale||60,000||12.84||770,520|
|2005-04-01||Trause Robert W (Director)||Sale||23,428||19.46||455,791|
Insider trading activities including stock purchases, stock sales, and option exercises of DCAI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dialysis Corp Of America (symbol DCAI, CIK number 201653) see the Securities and Exchange Commission (SEC) website.